First National Bank of Omaha Reduces Stake in Amgen Inc.

First National Bank of Omaha has reduced its stake in Amgen Inc. (NASDAQ:AMGN) by 9.9% in the second quarter, according to a recent disclosure with the Securities and Exchange Commission (SEC).

The bank owned 43,308 shares of Amgen's stock after selling 4,746 shares during the quarter, valuing its holdings at $15,652,000.

Amgen has been performing well, with revenue up 9.5% compared to the same period last year, and a return on equity of 124.14%. The company has set its FY 2026 guidance at 22.300-23.500 EPS.